TerminatedNCT05419986
Epigenetic Biomarker for Addiction
Study assessmentsAges 18+France
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- StrasbourgSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 23, 2022
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 11
- Sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- GENETIC
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- Over 18 Years
- Official registry ID
- NCT05419986
- Official title
Show the full official title
Are Epigenetic Biomarkers an Indicator of the Severity of Addiction in Active Opiate Abusers? A Pilot Study
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Strasbourg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Strasbourg, France, a hospital or academic medical center.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
Benefit of Systematic Proposition of Nicotine Substitution for Patients Undergoing Surgery
Effects of Prenatal Alcohol Exposure on Emotional and Cognitive Abilities in Adults